OB/GYN Clinical Alert
RSSArticles
-
Accuracy of Laparoscopic Diagnosis of PID
Compared to histopathology, visual diagnosis of PID is neither accurate nor reproducible. -
Intraperitoneal Radioactive Phosphorus (32P) vs Observation After Negative Second-Look Laparotomy for Stage III Ovarian Carcinoma
Intraperitoneal chromic phosphate did not decrease the risk of relapse or improve survival for patients with stage III epithelial ovarian cancer after a negative second-look surgery. -
Management of Port-Site Metastasis After Laparoscopic Surgery for Ovarian Cancer
Port-site metastasis after laparoscopic surgery during chemotherapy, or when adequate chemotherapy has been given, is usually associated with poor outcome. -
Prevention of Breast Cancer with Tamoxifen
Only 5% of white women and 0.6% of black women are potential candidates for tamoxifen chemoprevention. -
Use of OCP’s to Eliminate Withdrawal Bleeding
Daily administration of a low dose oral birth control pill results in significantly fewer bleeding days. -
Death by a Thousand Indignities: The Saga of HRT
This week there were 2 articles in the New England Journal of Medicine that explored the link between postmenopausal hormone use and heart disease. The first article was the final analysis of the Prempro® arm of the WHI. -
Seasonale: A Revolutionary Contraceptive
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Vardenafil Will Compete for Share of ED Market
The FDA has approved vardenafil (LevitraBayer and GlaxoSmithKline) for the treatment of erectile dysfunction in men. Vardenafil joins sildenafil (Viagra) as the only 2 drugs approved for this indication in this country. -
‘It’s Déjà vu All Over Again’ *
Weekly injections of alpha-hydroxyprogesterone caproate resulted in a substantial reduction in the rate of recurrent preterm delivery among women who were at particularly high risk for preterm delivery and reduced the likelihood of several complications in their infants.